Sjögren's disease & overlap diseases

Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome

Joint Bone SpinePublished Cross-sectional study

Authors' conclusion

The detection of MSG monoclonal B-cell expansion by this easy-to-perform molecular assay is useful, both at the time of diagnosis and during the course of SS. Monoclonal B-cell expansion is associated with a subset of SS patients presenting either ongoing lymphoma or other established lymphoma predictive factors.

Study context

Population
Patients with suspected Sjögren's syndrome (SS) or suspected lymphoma during SS; fresh-frozen minor salivary glands (MSG)
Participants
207 patients
Exposure
SS vs no SS
  • SSn = 123
  • Without SSn = 84reference
Outcome
Prevalence of clonal immunoglobulin gene rearrangements (monoclonal B-cell infiltration) in MSG
Methodological detailsstandardised multiplex PCR assay with heteroduplex analysis by microcapillary electrophoresis, EuroClonality consortium guidelines
  • Standardised multiplex PCR assay with heteroduplex analysis by microcapillary electrophoresis
  • EuroClonality consortium guidelines

Main finding

As reported in the abstract

MSG monoclonal B-cell infiltration

P < 0.001

MSG monoclonal B-cell infiltration, all patients
31 (15%)

Observational data: associations, not effects.

Further findings

Correlates of MSG monoclonality in SS

Correlated significantly with ongoing salivary gland non-Hodgkin's lymphoma (NHL), salivary gland swelling, CD4+ T-cell lymphopenia, rheumatoid factor (RF) activity, low complement and type 2 mixed cryoglobulinemia

Probability of MSG B-cell monoclonality by accumulation of biological risk factors

Only positive RF
no probability
RF-positive with 1 other risk factor
25.0%
RF-positive with 2 other risk factors
85.7%

Original publication

Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome. Joint Bone Spine. Published 29 December 2023. doi:10.1016/j.jbspin.2023.105686

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.